[go: up one dir, main page]

IL192230A0 - Pharmaceutical formulations of fenofibrate having improved bioavailability - Google Patents

Pharmaceutical formulations of fenofibrate having improved bioavailability

Info

Publication number
IL192230A0
IL192230A0 IL192230A IL19223008A IL192230A0 IL 192230 A0 IL192230 A0 IL 192230A0 IL 192230 A IL192230 A IL 192230A IL 19223008 A IL19223008 A IL 19223008A IL 192230 A0 IL192230 A0 IL 192230A0
Authority
IL
Israel
Prior art keywords
fenofibrate
pharmaceutical formulations
improved bioavailability
bioavailability
improved
Prior art date
Application number
IL192230A
Original Assignee
Teva Pharma
Fleshner Barak Moshe
Lerner Itzhak
Rosenberger Vered
Moldavski Naomi
Drabkin Anna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma, Fleshner Barak Moshe, Lerner Itzhak, Rosenberger Vered, Moldavski Naomi, Drabkin Anna filed Critical Teva Pharma
Publication of IL192230A0 publication Critical patent/IL192230A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL192230A 2005-12-28 2008-06-16 Pharmaceutical formulations of fenofibrate having improved bioavailability IL192230A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2005/047346 WO2007075171A1 (en) 2005-12-28 2005-12-28 Pharmaceutical formulations of fenofibrate having improved bioavailability

Publications (1)

Publication Number Publication Date
IL192230A0 true IL192230A0 (en) 2008-12-29

Family

ID=36499668

Family Applications (1)

Application Number Title Priority Date Filing Date
IL192230A IL192230A0 (en) 2005-12-28 2008-06-16 Pharmaceutical formulations of fenofibrate having improved bioavailability

Country Status (7)

Country Link
JP (1) JP2009522258A (en)
CN (1) CN101351191A (en)
BR (1) BRPI0520821A2 (en)
CA (1) CA2634094A1 (en)
IL (1) IL192230A0 (en)
MX (1) MX2008008589A (en)
WO (1) WO2007075171A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120225946A1 (en) * 2009-09-09 2012-09-06 Bernard Charles Sherman Choline fenofibrate delayed release compositions
US9492535B2 (en) 2013-03-14 2016-11-15 Aimmune Therapeutics, Inc. Peanut formulations and uses thereof
CN109125283A (en) * 2013-03-14 2019-01-04 艾慕恩治疗公司 The preparation of peanut preparation for oral desensitization
KR101850119B1 (en) 2015-11-11 2018-04-20 제이투에이치바이오텍 (주) Novel Fenofibric Acid Prodrugs with Improved Bioavailability
EP3897681A4 (en) 2018-12-20 2022-10-26 Société des Produits Nestlé S.A. Peanut oral immunotherapy dosing schedule for missed doses
CA3137295A1 (en) 2019-05-10 2020-11-19 Aimmune Therapeutics, Inc. Methods for improving the quality of life of a patient with a peanut allergy
CN112618511A (en) * 2020-12-31 2021-04-09 辰欣药业股份有限公司 Prescription composition of fenofibrate capsule and preparation process thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2627696B1 (en) * 1988-02-26 1991-09-13 Fournier Innovation Synergie NEW GALENIC FORM OF FENOFIBRATE
FR2758459B1 (en) * 1997-01-17 1999-05-07 Pharma Pass FENOFIBRATE PHARMACEUTICAL COMPOSITION HAVING HIGH BIODAVAILABILITY AND PROCESS FOR PREPARING THE SAME
US6368622B2 (en) * 1999-01-29 2002-04-09 Abbott Laboratories Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption
DE60129573T2 (en) * 2000-09-20 2008-04-17 Jagotec Ag PROCESS FOR SPRAY DRYING OF COMPOSITIONS CONTAINING FENOFIBRATE
IL164152A0 (en) * 2002-03-26 2005-12-18 Teva Pharma Drug microparticles
BRPI0415121A (en) * 2003-10-10 2006-11-28 Lifecycle Pharma As particulate material, solid dosage form, method of manufacturing it, and use of a particulate material or solid dosage form
KR20130103818A (en) * 2003-10-10 2013-09-24 벨로시스 파마슈티컬스 에이/에스 A solid dosage form comprising a fibrate

Also Published As

Publication number Publication date
JP2009522258A (en) 2009-06-11
MX2008008589A (en) 2009-02-25
CA2634094A1 (en) 2007-07-05
CN101351191A (en) 2009-01-21
WO2007075171A1 (en) 2007-07-05
BRPI0520821A2 (en) 2009-06-30

Similar Documents

Publication Publication Date Title
IL177566A0 (en) Pharmaceutical formulations
ZA200900345B (en) Preparation of pharmaceutical formulations
HK1152478A1 (en) Solid pharmaceutical formulations comprising bibw 2992
ITBO20050123A1 (en) GASTRORESISTIC PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMINA
IL187957A0 (en) Liquid pharmaceutical formulations of docetaxel
NO20075628L (en) Pharmaceutical formulations
GB0426301D0 (en) Pharmaceutical formulations
IL185390A (en) Solid pharmaceutical dosage formulation
ZA200801275B (en) Pharmaceutical preparation containing meloxicam
ZA200705530B (en) Sustained release pharmaceutical formulations
EP1895991A4 (en) Modified release formulations of anti-irritability drugs
EP2112925A4 (en) Solid pharmaceutical dosage formulations
IL180031A0 (en) Stable pharmaceutical formulations of benzimidazole compounds
GB0520656D0 (en) Pharmaceutical compounds
HK1134902A1 (en) Compounds a-r-x for the manufacture of pharmaceutical preparations
IL192230A0 (en) Pharmaceutical formulations of fenofibrate having improved bioavailability
ZA200803152B (en) Oramucosal pharmaceutical dosage form
ZA200708699B (en) Pharmaceutical formulations amyloid inhibiting compounds
EP1853238A4 (en) Pharmaceutical formulations containing 17-allylamino-17-demethoxygeldanamycin
GB0416397D0 (en) Pharmaceutical formulations
GB0423800D0 (en) New pharmaceutical formulations
IL198160A0 (en) Pharmaceutical formulations
GB0406048D0 (en) Drug formulations
EP1864664A4 (en) Pharmaceutical preparation
GB0501475D0 (en) Pharmaceutical compounds